Biotechnology Market Size, Share & Trend Analysis By Technology (Nanobiotechnology, DNA Sequencing, Cell-based Assays), By Application (Health, Bioinformatics), By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Biotechnology Market: Methodology and Scope
                   1.1. Information Procurement
                   1.2. Information Or Data Analysis
                   1.3. Market Scope & Segment Definition
                   1.4. Market Model
                       1.4.1. Market Study, By Company Market Share
                       1.4.2. Regional Analysis
Chapter 2. Biotechnology Market: Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Biotechnology Market: Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Presence Of Favorable Government Initiatives
                           3.2.1.2. Rising Demand For Agro-Based Products
                           3.2.1.3. Growing Demand For Synthetic Biology
                           3.2.1.4. Declining Prices Of DNA Sequencing
                           3.2.1.5. Growing Healthcare Expenditure Boosting Development Of Effective Personalized Diagnostic & Therapeutic Procedures For Cancer
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. Ethical & Legal Limitations
                           3.2.2.2. Risks Associated With GM Organisms And Crops
                           3.2.2.3. Challenges Associated With NGS Implementation
                   3.3. Industry Analysis Tools
                       3.3.1. Porter’s Five Forces Analysis
                       3.3.2. PESTEL Analysis
                       3.3.3. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
                   4.1. Biotechnology Market: Technology Movement Analysis
                   4.2. Nanobiotechnology
                       4.2.1. Nanobiotechnology Market, 2018 - 2030 (USD Billion)
                   4.3. Tissue Engineering and Regeneration
                       4.3.1. Tissue Engineering and Regeneration Market, 2018 - 2030 (USD Billion)
                   4.4. DNA Sequencing
                       4.4.1. DNA Sequencing Market, 2018 - 2030 (USD Billion)
                   4.5. Cell-based Assays
                       4.5.1. Cell-based Assays Market, 2018 - 2030 (USD Billion)
                   4.6. Fermentation
                       4.6.1. Fermentation Market, 2018 - 2030 (USD Billion)
                   4.7. PCR Technology
                       4.7.1. PCR Technology Market, 2018 - 2030 (USD Billion)
                   4.8. Chromatography
                       4.8.1. Chromatography Market, 2018 - 2030 (USD Billion)
                   4.9. Others
                       4.9.1. Other Technology Market, 2018 - 2030 (USD Billion)
Chapter 5. Application Business Analysis
                   5.1. Biotechnology Market: Application Movement Analysis
                   5.2. Health
                       5.2.1. Health Market, 2018 - 2030 (USD Billion)
                   5.3. Food & Agriculture
                       5.3.1. Food & Agriculture Market, 2018 - 2030 (USD Billion)
                   5.4. Natural Resources & Environment
                       5.4.1. Natural Resources & Environment Market, 2018 - 2030 (USD Billion)
                   5.5. Industrial Processing
                       5.5.1. Industrial Processing Market, 2018 - 2030 (USD Billion)
                   5.6. Bioinformatics
                       5.6.1. Bioinformatics Market, 2018 - 2030 (USD Billion)
                   5.7. Others
                       5.7.1. Other Application Market, 2018 - 2030 (USD Billion)
Chapter 6. Regional Business Analysis
                   6.1. Biotechnology Market Share By Region, 2022 & 2030
                   6.2. North America
                       6.2.1. North America Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.2.2. U.S.
                           6.2.2.1. Key Country Dynamics
                           6.2.2.2. Target Disease Prevalence
                           6.2.2.3. Competitive Scenario
                           6.2.2.4. Regulatory Framework
                           6.2.2.5. Reimbursement Scenario
                           6.2.2.6. U.S. Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.2.3. Canada
                           6.2.3.1. Key Country Dynamics
                           6.2.3.2. Target Disease Prevalence
                           6.2.3.3. Competitive Scenario
                           6.2.3.4. Regulatory Framework
                           6.2.3.5. Reimbursement Scenario
                           6.2.3.6. Canada Biotechnology Market, 2018 - 2030 (USD Billion)
                   6.3. Europe
                       6.3.1. Europe Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.3.2. UK
                           6.3.2.1. Key Country Dynamics
                           6.3.2.2. Target Disease Prevalence
                           6.3.2.3. Competitive Scenario
                           6.3.2.4. Regulatory Framework
                           6.3.2.5. Reimbursement Scenario
                           6.3.2.6. UK Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.3.3. Germany
                           6.3.3.1. Key Country Dynamics
                           6.3.3.2. Target Disease Prevalence
                           6.3.3.3. Competitive Scenario
                           6.3.3.4. Regulatory Framework
                           6.3.3.5. Reimbursement Scenario
                           6.3.3.6. Germany Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.3.4. France
                           6.3.4.1. Key Country Dynamics
                           6.3.4.2. Target Disease Prevalence
                           6.3.4.3. Competitive Scenario
                           6.3.4.4. Regulatory Framework
                           6.3.4.5. Reimbursement Scenario
                           6.3.4.6. France Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.3.5. Italy
                           6.3.5.1. Key Country Dynamics
                           6.3.5.2. Target Disease Prevalence
                           6.3.5.3. Competitive Scenario
                           6.3.5.4. Regulatory Framework
                           6.3.5.5. Reimbursement Scenario
                           6.3.5.6. Italy Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.3.6. Spain
                           6.3.6.1. Key Country Dynamics
                           6.3.6.2. Target Disease Prevalence
                           6.3.6.3. Competitive Scenario
                           6.3.6.4. Regulatory Framework
                           6.3.6.5. Reimbursement Scenario
                           6.3.6.6. Spain Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.3.7. Denmark
                           6.3.7.1. Key Country Dynamics
                           6.3.7.2. Target Disease Prevalence
                           6.3.7.3. Competitive Scenario
                           6.3.7.4. Regulatory Framework
                           6.3.7.5. Reimbursement Scenario
                           6.3.7.6. Denmark Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.3.8. Sweden
                           6.3.8.1. Key Country Dynamics
                           6.3.8.2. Target Disease Prevalence
                           6.3.8.3. Competitive Scenario
                           6.3.8.4. Regulatory Framework
                           6.3.8.5. Reimbursement Scenario
                           6.3.8.6. Sweden Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.3.9. Norway
                           6.3.9.1. Key Country Dynamics
                           6.3.9.2. Target Disease Prevalence
                           6.3.9.3. Competitive Scenario
                           6.3.9.4. Regulatory Framework
                           6.3.9.5. Reimbursement Scenario
                           6.3.9.6. Norway Biotechnology Market, 2018 - 2030 (USD Billion)
                   6.4. Asia Pacific
                       6.4.1. Asia Pacific Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.4.2. Japan
                           6.4.2.1. Key Country Dynamics
                           6.4.2.2. Target Disease Prevalence
                           6.4.2.3. Competitive Scenario
                           6.4.2.4. Regulatory Framework
                           6.4.2.5. Reimbursement Scenario
                           6.4.2.6. Japan Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.4.3. China
                           6.4.3.1. Key Country Dynamics
                           6.4.3.2. Target Disease Prevalence
                           6.4.3.3. Competitive Scenario
                           6.4.3.4. Regulatory Framework
                           6.4.3.5. Reimbursement Scenario
                           6.4.3.6. China Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.4.4. India
                           6.4.4.1. Key Country Dynamics
                           6.4.4.2. Target Disease Prevalence
                           6.4.4.3. Competitive Scenario
                           6.4.4.4. Regulatory Framework
                           6.4.4.5. Reimbursement Scenario
                           6.4.4.6. India Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.4.5. Australia
                           6.4.5.1. Key Country Dynamics
                           6.4.5.2. Target Disease Prevalence
                           6.4.5.3. Competitive Scenario
                           6.4.5.4. Regulatory Framework
                           6.4.5.5. Reimbursement Scenario
                           6.4.5.6. Australia Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.4.6. Thailand
                           6.4.6.1. Key Country Dynamics
                           6.4.6.2. Target Disease Prevalence
                           6.4.6.3. Competitive Scenario
                           6.4.6.4. Regulatory Framework
                           6.4.6.5. Reimbursement Scenario
                           6.4.6.6. Thailand Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.4.7. South Korea
                           6.4.7.1. Key Country Dynamics
                           6.4.7.2. Target Disease Prevalence
                           6.4.7.3. Competitive Scenario
                           6.4.7.4. Regulatory Framework
                           6.4.7.5. Reimbursement Scenario
                           6.4.7.6. South Korea Biotechnology Market, 2018 - 2030 (USD Billion)
                   6.5. Latin America
                       6.5.1. Latin America Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.5.2. Brazil
                           6.5.2.1. Key Country Dynamics
                           6.5.2.2. Target Disease Prevalence
                           6.5.2.3. Competitive Scenario
                           6.5.2.4. Regulatory Framework
                           6.5.2.5. Reimbursement Scenario
                           6.5.2.6. Brazil Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.5.3. Mexico
                           6.5.3.1. Key Country Dynamics
                           6.5.3.2. Target Disease Prevalence
                           6.5.3.3. Competitive Scenario
                           6.5.3.4. Regulatory Framework
                           6.5.3.5. Reimbursement Scenario
                           6.5.3.6. Mexico Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.5.4. Argentina
                           6.5.4.1. Key Country Dynamics
                           6.5.4.2. Target Disease Prevalence
                           6.5.4.3. Competitive Scenario
                           6.5.4.4. Regulatory Framework
                           6.5.4.5. Reimbursement Scenario
                           6.5.4.6. Argentina Biotechnology Market, 2018 - 2030 (USD Billion)
                   6.6. MEA
                       6.6.1. MEA Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.6.2. South Africa
                           6.6.2.1. Key Country Dynamics
                           6.6.2.2. Target Disease Prevalence
                           6.6.2.3. Competitive Scenario
                           6.6.2.4. Regulatory Framework
                           6.6.2.5. Reimbursement Scenario
                           6.6.2.6. Reimbursement Scenario
                           6.6.2.7. South Africa Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.6.3. Saudi Arabia
                           6.6.3.1. Key Country Dynamics
                           6.6.3.2. Target Disease Prevalence
                           6.6.3.3. Competitive Scenario
                           6.6.3.4. Regulatory Framework
                           6.6.3.5. Reimbursement Scenario
                           6.6.3.6. Saudi Arabia Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.6.4. UAE
                           6.6.4.1. Key Country Dynamics
                           6.6.4.2. Target Disease Prevalence
                           6.6.4.3. Competitive Scenario
                           6.6.4.4. Regulatory Framework
                           6.6.4.5. Reimbursement Scenario
                           6.6.4.6. UAE Biotechnology Market, 2018 - 2030 (USD Billion)
                       6.6.5. Kuwait
                           6.6.5.1. Key Country Dynamics
                           6.6.5.2. Target Disease Prevalence
                           6.6.5.3. Competitive Scenario
                           6.6.5.4. Regulatory Framework
                           6.6.5.5. Reimbursement Scenario
                           6.6.5.6. Kuwait Biotechnology Market, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
                   7.1. Company Categorization
                   7.2. Strategy Mapping
                   7.3. Company Market Share Analysis, 2022
                   7.4. Company Profiles/Listing
                       7.4.1. AstraZeneca
                           7.4.1.1. Overview
                           7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.1.3. Product Benchmarking
                           7.4.1.4. Strategic Initiatives
                       7.4.2. Gilead Sciences, Inc.
                           7.4.2.1. Overview
                           7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.2.3. Product Benchmarking
                           7.4.2.4. Strategic Initiatives
                       7.4.3. Bristol-Myers Squibb
                           7.4.3.1. Overview
                           7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.3.3. Product Benchmarking
                           7.4.3.4. Strategic Initiatives
                       7.4.4. Sanofi
                           7.4.4.1. Overview
                           7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.4.3. Product Benchmarking
                           7.4.4.4. Strategic Initiatives
                       7.4.5. Biogen
                           7.4.5.1. Overview
                           7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.5.3. Product Benchmarking
                           7.4.5.4. Strategic Initiatives
                       7.4.6. Abbott Laboratories
                           7.4.6.1. Overview
                           7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.6.3. Product Benchmarking
                           7.4.6.4. Strategic Initiatives
                       7.4.7. Pfizer, Inc.
                           7.4.7.1. Overview
                           7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.7.3. Product Benchmarking
                           7.4.7.4. Strategic Initiatives
                       7.4.8. Amgen, Inc.
                           7.4.8.1. Overview
                           7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.8.3. Product Benchmarking
                           7.4.8.4. Strategic Initiatives
                       7.4.9. Novo Nordisk A/S
                           7.4.9.1. Overview
                           7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.9.3. Product Benchmarking
                           7.4.9.4. Strategic Initiatives
                       7.4.10. Merck KGaA
                           7.4.10.1. Overview
                           7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.10.3. Product Benchmarking
                           7.4.10.4. Strategic Initiatives
                       7.4.11. Johnson & Johnson Services, Inc.
                           7.4.11.1. Overview
                           7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.11.3. Product Benchmarking
                           7.4.11.4. Strategic Initiatives
                       7.4.12. Novartis AG
                           7.4.12.1. Overview
                           7.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.12.3. Product Benchmarking
                           7.4.12.4. Strategic Initiatives
                       7.4.13. F. Hoffmann-La Roche Ltd.
                           7.4.13.1. Overview
                           7.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.13.3. Product Benchmarking
                           7.4.13.4. Strategic Initiatives
                       7.4.14. Lonza
                           7.4.14.1. Overview
                           7.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           7.4.14.3. Product Benchmarking
                           7.4.14.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Global biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 3 Global biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 4 Global biotechnology market, by region, 2018 - 2030 (USD Billion)
Table 5 North America biotechnology market, by country, 2018 - 2030 (USD Billion)
Table 6 North America biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 7 North America biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 8 U.S. biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 9 U.S. biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 10 Canada biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 11 Canada biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 12 Europe biotechnology market, by country, 2018 - 2030 (USD Billion)
Table 13 Europe biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 14 Europe biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 15 UK biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 16 UK biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 17 Germany biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 18 Germany biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 19 France biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 20 France biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 21 Italy biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 22 Italy biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 23 Spain biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 24 Spain biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 25 Denmark biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 26 Denmark biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 27 Sweden biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 28 Sweden biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 29 Norway biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 30 Norway biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 31 Asia Pacific biotechnology market, by country, 2018 - 2030 (USD Billion)
Table 32 Asia Pacific biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 33 Asia Pacific biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 34 Japan biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 35 Japan biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 36 China biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 37 China biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 38 India biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 39 India biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 40 Australia biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 41 Australia biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 42 Thailand biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 43 Thailand biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 44 South Korea biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 45 South Korea biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 46 Latin America biotechnology market, by country, 2018 - 2030 (USD Billion)
Table 47 Latin America biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 48 Latin America biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 49 Brazil biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 50 Brazil biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 51 Mexico biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 52 Mexico biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 53 Argentina biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 54 Argentina biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 55 Middle East & Africa biotechnology market, by country, 2018 - 2030 (USD Billion)
Table 56 Middle East & Africa biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 57 Middle East & Africa biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 58 South Africa biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 59 South Africa biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 60 Saudi Arabia biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 61 Saudi Arabia biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 62 UAE biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 63 UAE biotechnology market, by application, 2018 - 2030 (USD Billion)
Table 64 Kuwait biotechnology market, by technology, 2018 - 2030 (USD Billion)
Table 65 Kuwait biotechnology market, by application, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Biotechnology market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Global biotechnology market: Technology movement analysis
Fig. 15 Global biotechnology market, for nanobiotechnology, 2018 - 2030 (USD Billion)
Fig. 16 Global biotechnology market, for tissue engineering & regeneration, 2018 - 2030 (USD Billion)
Fig. 17 Global biotechnology market, for DNA sequencing, 2018 - 2030 (USD Billion)
Fig. 18 Global biotechnology market, for cell-based assays, 2018 - 2030 (USD Billion)
Fig. 19 Global biotechnology market, for fermentation, 2018 - 2030 (USD Billion)
Fig. 20 Global biotechnology market, for PCR technology, 2018 - 2030 (USD Billion)
Fig. 21 Global biotechnology market, for chromatography, 2018 - 2030 (USD Billion)
Fig. 22 Global biotechnology market, for other technologies, 2018 - 2030 (USD Billion)
Fig. 23 Global biotechnology market: Application movement analysis
Fig. 24 Global biotechnology market, for health, 2018 - 2030 (USD Billion)
Fig. 25 Global biotechnology market, for food & agriculture, 2018 - 2030 (USD Billion)
Fig. 26 Global biotechnology market, for natural resources & environment, 2018 - 2030 (USD Billion)
Fig. 27 Global biotechnology market, for industrial processing, 2018 - 2030 (USD Billion)
Fig. 28 Global biotechnology market, for bioinformatics, 2018 - 2030 (USD Billion)
Fig. 29 Global biotechnology market, for other applications, 2018 - 2030 (USD Billion)
Fig. 30 Regional marketplace: Key takeaways
Fig. 31 Regional outlook, 2022 & 2030
Fig. 32 Global biotechnology market: Region movement analysis
Fig. 33 North America biotechnology market, 2018 - 2030 (USD Billion)
Fig. 34 U.S. biotechnology market, 2018 - 2030 (USD Billion)
Fig. 35 Canada biotechnology market, 2018 - 2030 (USD Billion)
Fig. 36 Europe biotechnology market, 2018 - 2030 (USD Billion)
Fig. 37 Germany biotechnology market, 2018 - 2030 (USD Billion)
Fig. 38 UK biotechnology market, 2018 - 2030 (USD Billion)
Fig. 39 France biotechnology market, 2018 - 2030 (USD Billion)
Fig. 40 Italy biotechnology market, 2018 - 2030 (USD Billion)
Fig. 41 Spain biotechnology market, 2018 - 2030 (USD Billion)
Fig. 42 Denmark biotechnology market, 2018 - 2030 (USD Billion)
Fig. 43 Sweden biotechnology market, 2018 - 2030 (USD Billion)
Fig. 44 Norway biotechnology market, 2018 - 2030 (USD Billion)
Fig. 45 Asia Pacific biotechnology market, 2018 - 2030 (USD Billion)
Fig. 46 Japan biotechnology market, 2018 - 2030 (USD Billion)
Fig. 47 China biotechnology market, 2018 - 2030 (USD Billion)
Fig. 48 India biotechnology market, 2018 - 2030 (USD Billion)
Fig. 49 Australia biotechnology market, 2018 - 2030 (USD Billion)
Fig. 50 Thailand biotechnology market, 2018 - 2030 (USD Billion)
Fig. 51 South Korea biotechnology market, 2018 - 2030 (USD Billion)
Fig. 52 Latin America biotechnology market, 2018 - 2030 (USD Billion)
Fig. 53 Brazil biotechnology market, 2018 - 2030 (USD Billion)
Fig. 54 Mexico biotechnology market, 2018 - 2030 (USD Billion)
Fig. 55 Argentina biotechnology market, 2018 - 2030 (USD Billion)
Fig. 56 Middle East and Africa biotechnology market, 2018 - 2030 (USD Billion)
Fig. 57 South Africa biotechnology market, 2018 - 2030 (USD Billion)
Fig. 58 Saudi Arabia biotechnology market, 2018 - 2030 (USD Billion)
Fig. 59 UAE biotechnology market, 2018 - 2030 (USD Billion)
Fig. 60 Kuwait biotechnology market, 2018 - 2030 (USD Billion)